Cure My Disease

Don't miss your cure!

 Log in / Sign up

Nurse-Assisted eye test app could revolutionize senior vision care

NCT ID NCT06058637

Diagnosis Sponsor: Amsterdam UMC, location VUmc Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 2 times

Summary

This study tested whether a nurse-assisted online eye screening app (Easee) is cost-effective for older adults receiving home healthcare. 234 participants aged 65+ used the app with a nurse's help to check their vision. The goal was to see if this approach reduces eye complaints and is worth the cost.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Easee app eye screening device
What this could lead to
If successful, this could provide a convenient, cost-effective way to screen for eye problems in older adults receiving home care, potentially catching issues earlier.
What could go wrong
This is a completed implementation study, not a treatment trial. It assesses feasibility and cost-effectiveness, not clinical outcomes. Results may not apply to all settings or populations.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

234 people

The number who actually took part.

Started

Mar 2023

Finished

Nov 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

65 years and older

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion criteria * Patients receive home healthcare for health problems * 65 years or older * Understanding of the Dutch language * Cognitive ability to participate in research (six-item Mini Mental State Examination: score \>3) Exclusion criteria * Very serious health condition of the patient (i.e. terminal illness, receiving palliative home care) * Cognitively unable to participate in research (e.g. late stage Alzheimer's/Dementia, Parkinson's) (six-item Mini Mental State Examination: score ≤3) * Having received an optometric or ophthalmic consultation within the last 6 months

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Eye diseases are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

eye disorder vision disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Eye diseases

Contacts and locations

Locations

  • Amsterdam UMC

    Amsterdam, Netherlands

More trials for these conditions

Other studies related to the condition(s) this trial covers.